Read the full article here.
This content was originally published by BusinessLIVE. Original publishers retain all rights. It appears here for a limited time before automated archiving. By BusinessLIVE
Global equities rallied on news that the US Food and Drug Administration authorised the use of blood plasma as a treatment for Covid-19